Phillip G. Febbo net worth and biography

Phillip Febbo Biography and Net Worth

Insider of Veracyte

Phillip G. Febbo joined Veracyte in 2023 and serves as Chief Scientific Officer and Chief Medical Officer. Dr. Febbo is a distinguished life sciences leader with more than 25 years of experience across academia and the molecular diagnostics industry. Prior to Veracyte, he served as Chief Medical Officer for Illumina where he led the successful strategy to engage clinical customers. Prior to that, he was Chief Medical Officer for Genomic Health, where he oversaw the development and expansion of the company’s test portfolio. Earlier in his career, Dr. Febbo was a Professor of Medicine and Urology at the University of California, San Francisco Medical Center, and before that he was an Associate Professor of Medicine and Molecular Genetics and Microbiology at Duke University School of Medicine. He currently serves on the board of the Reagan Udall Foundation for the U.S. Food and Drug Administration (FDA) and was previously a director for Varian, Inc. Dr. Febbo holds a B.A. in Biology from Dartmouth College and an M.D. from the University of California, San Francisco. He completed his internal medicine residency at Brigham and Women’s Hospital and his medical oncology fellowship at the Dana Farber Cancer Institute.

What is Phillip G. Febbo's net worth?: The estimated net worth of Phillip G. Febbo is at least $4.38 million as of October 6th, 2025. Febbo owns 92,441 shares of Veracyte stock worth more than $4,382,628 as of December 4th. This net worth evaluation does not reflect any other assets that Febbo may own. Additionally, Febbo receives a salary of $657,740.00 as Insider at Veracyte. Learn More about Phillip G. Febbo's net worth.
How old is Phillip G. Febbo?: Febbo is currently 58 years old. There are 6 older executives and no younger executives at Veracyte. Learn More on Phillip G. Febbo's age.
What is Phillip G. Febbo's salary?: As the Insider of Veracyte, Inc., Febbo earns $657,740.00 per year. There are 4 executives that earn more than Febbo. The highest earning executive at Veracyte is Mr. Marc A. Stapley, CEO & Director, who commands a salary of $1,550,000.00 per year. Learn More on Phillip G. Febbo's salary.
How do I contact Phillip G. Febbo?: The corporate mailing address for Febbo and other Veracyte executives is 6000 SHORELINE COURT SUITE 300, SOUTH SAN FRANCISCO CA, 94080. Veracyte can also be reached via phone at (650) 243-6300 and via email at [email protected]. Learn More on Phillip G. Febbo's contact information.
Has Phillip G. Febbo been buying or selling shares of Veracyte?: Over the course of the past ninety days, Phillip G. Febbo has sold $300,730.98 of Veracyte stock. Most recently, Phillip G. Febbo sold 8,349 shares of the business's stock in a transaction on Monday, October 6th. The shares were sold at an average price of $36.02, for a transaction totalling $300,730.98. Following the completion of the sale, the insider now directly owns 92,441 shares of the company's stock, valued at $3,329,724.82. Learn More on Phillip G. Febbo's trading history.
Who are Veracyte's active insiders?: Veracyte's insider roster includes Bonnie Anderson (Insider), Muna Bhanji (Director), Rebecca Chambers (Exec. VP & CFO ), Rebecca Chambers (CFO), Karin Eastham (Director), Phillip Febbo (Insider), Jens Holstein (Director), Evan Jones (Director), Giulia Kennedy (Insider), John Leite (Chief Commercial Officer, CLIA Business), Annie Mcguire (SVP), Marc Stapley (CEO), Marc Stapley (CEO & Director), Jonathan Wygant (CAO), and Jonathan Wygant (CAO). Learn More on Veracyte's active insiders.
Are insiders buying or selling shares of Veracyte?: In the last year, insiders at the biotechnology company sold shares 16 times. They sold a total of 132,722 shares worth more than $5,646,695.43. The most recent insider tranaction occured on December, 4th when SVP Annie Mcguire sold 1,422 shares worth more than $67,260.60. Insiders at Veracyte own 1.4% of the company. Learn More about insider trades at Veracyte.
Information on this page was last updated on 12/4/2025.

Phillip G. Febbo Insider Trading History at Veracyte

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
10/6/2025	Sell	8,349	$36.02	$300,730.98	92,441

Phillip G. Febbo Buying and Selling Activity at Veracyte

Veracyte Company Overview

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.

Today's Range

Now: $47.41

$46.02

$47.78

50 Day Range

MA: $39.11

$33.44

$49.38

2 Week Range

Now: $47.41

$22.61

$50.71

Volume

895,484 shs

Average Volume

974,443 shs

Market Capitalization

$3.75 billion

P/E Ratio

124.77

Dividend Yield

N/A

Beta

1.83

Phillip Febbo Biography and Net Worth

What is Phillip G. Febbo's net worth?

How old is Phillip G. Febbo?

What is Phillip G. Febbo's salary?

How do I contact Phillip G. Febbo?

Has Phillip G. Febbo been buying or selling shares of Veracyte?

Who are Veracyte's active insiders?

Are insiders buying or selling shares of Veracyte?